Tarin D, Vass A C, Kettlewell M G, Price J E
Invasion Metastasis. 1984;4(1):1-12.
This communication records a remarkable case illustrating both the clinical value of peritoneo-venous shunting in the management of malignant ascites, and the unique opportunity afforded by this procedure for investigation of factors which influence metastatic colony formation by disseminating human tumour cells. The study of patients treated with peritoneo-venous shunts for the purpose of obtaining information on metastasis is ethically sound because such treatment is used solely for relief of the patient's clinical condition, and investigative procedures involving the patient are limited to those necessary for good clinical management. The patient we present survived for 27 months following insertion of a peritoneo-venous shunt, and for most of this time had a functioning shunt judged by clinical criteria. At autopsy she was found to have no established metastases in any organ, although viable, clonogenic cancer cells clearly capable of forming large secondary growths in the abdominal cavity were delivered directly into the bloodstream.
本报告记录了一个引人注目的病例,该病例既说明了腹腔静脉分流术在治疗恶性腹水方面的临床价值,也展示了此手术为研究影响播散性人类肿瘤细胞形成转移瘤的因素提供的独特机会。为获取转移相关信息而对接受腹腔静脉分流术治疗的患者进行研究,在伦理上是合理的,因为这种治疗仅用于缓解患者的临床症状,且涉及患者的调查程序仅限于良好临床管理所必需的那些。我们所呈现的患者在植入腹腔静脉分流术后存活了27个月,在这段时间的大部分时间里,根据临床标准判断分流功能良好。尸检发现,她的任何器官均未出现已形成的转移灶,尽管能够在腹腔内形成大量继发性肿瘤的有活力、可克隆的癌细胞被直接输入了血流。